Latest Articles

Publication Date
Severe endometriosis surgeries linked to Melbourne gynaecologist under scrutiny - Neos Kosmos

Severe endometriosis surgeries linked to Melbourne gynaecologist under scrutiny Neos Kosmos

Published: Feb. 26, 2026, 6:53 a.m.
Courtney's doctor operated seven times to treat severe endometriosis experts say she didn't have - RNZ

Courtney's doctor operated seven times to treat severe endometriosis experts say she didn't have RNZ

Published: Feb. 13, 2026, 10:47 p.m.
Characteristics of adolescent and young adult patients undergoing surgery for deep endometriosis: a multicentre database study.

To determine the characteristics of adolescent and young adult patients undergoing surgery for severe endometriosis.

Published: Feb. 4, 2026, midnight
Validation of the deep pelvis endometriosis index (dPEI) to evaluate surgical outcomes of robotic-assisted surgery for endometriosis.

The Deep Pelvic Endometriosis Index (dPEI) is a preoperative MRI-based score initially validated to predict surgical outcomes in patients undergoing laparoscopic treatment for deep pelvic endometriosis (DPE). Its applicability in …

Published: Jan. 19, 2026, midnight
Unavoidable forever chemicals may be associated with severe endometriosis - MSN

Unavoidable forever chemicals may be associated with severe endometriosis MSN

Published: Jan. 18, 2026, 2:45 a.m.
Correlation between Polycomb repressive complex proteins and epithelial-mesenchymal transition-associated genes in endometriotic tissues.

Endometriosis is a condition in which functional endometrial glands and stroma are found to grow outside the uterine cavity that can lead to symptoms like dysmenorrhea, dyspareunia, adhesions, and infertility. …

Published: Dec. 19, 2025, midnight
Case Report: Diagnostic challenges in cervical small cell neuroendocrine carcinoma of a reproductive-age woman.

Small cell neuroendocrine carcinoma of the cervix (SCNEC) is a rare and highly aggressive malignancy with a poor prognosis. We report the case of a 36-year-old nulliparous woman with a …

Published: Nov. 10, 2025, midnight
Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain.

Elagolix (ELA) 200 mg twice daily is an oral treatment approved for moderate-to-severe endometriosis-associated pain. However, the clinical use of ELA is limited by potential hypoestrogenic effects, including the loss …

Published: Nov. 7, 2025, midnight
Limerick woman seeks vital support for surgery as severe endometriosis spreads to heart - The Irish Independent

Limerick woman seeks vital support for surgery as severe endometriosis spreads to heart The Irish Independent

Published: Oct. 6, 2025, 4 p.m.
Letter to the editor - Commentary on "Impact of a National Public Health Plan on the time frame for moderate and severe endometriosis diagnosis".

Published: Oct. 6, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!